New drug combo tested for Tough-to-Treat cancers
Disease control
Terminated
This early-stage study tested the safety of combining two experimental drugs, JS004 and toripalimab, in patients with advanced solid tumors like liver, stomach, and cervical cancer who had not responded to standard treatments. The main goal was to see if the combination was safe …
Phase: PHASE1 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 23:11 UTC